Lytenava
![Lytenava, Outlook Therapeutics, Avastin, Roche, wet AMD, bevacizumab-vikg, Complete response letter](https://pharmtales.com/wp-content/uploads/2023/08/Outlooks-eye-drug-Lytenava-fails-to-win-FDA-approval-despite-positive-trial.jpg)
Outlook’s eye drug Lytenava fails to win FDA approval, despite positive trial
Anika Sharma
Outlook Therapeutics has been working on a reformulated version of Roche’s cancer drug Avastin for the treatment of certain eye ...
Outlook Therapeutics has been working on a reformulated version of Roche’s cancer drug Avastin for the treatment of certain eye ...